FDA Withdraws PMA Plan For Cranial Electrotherapy Stimulators
This article was originally published in The Gray Sheet
Executive Summary
CDRH withdrew a prior proposal to require PMAs and class III risk-status for cranial electrotherapy stimulators, and now says it plans to downclassify the devices into class II, with special controls.